Home / News / International / Suven Life Sciences secures product patents in Australia, Hong Kong

Suven Life Sciences secures product patents in Australia, Hong Kong

Suven Life Science has secured one product patent from Australia and one product patent from Hong Kong corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2036 and 2033 respectively.

The granted claims of the patents include the class of selective M1 PAM and 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia etc.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

x

Check Also

NASA picks ancient Martian river delta for 2020 rover touchdown

NASA picks ancient Martian river delta for 2020 rover touchdown

NASA has picked an ancient river delta as the landing site for ...

Educational institutions built with Indian assistance inaugurated

Educational institutions built with Indian assistance inaugurated

In Nepal, three educational institutions built with the Indian assistance of 126.60 ...